Cardiac Troponin and BNP Together: Better Heart Failure Diagnosis
Combined use of high-sensitivity troponin-T and NT-proBNP natriuretic peptide provides superior heart failure diagnostic utility compared to either biomarker alone.
Quick Facts
What This Study Found
Combined use of high-sensitivity troponin-T and NT-proBNP natriuretic peptide provides superior heart failure diagnostic utility compared to either biomarker alone.
Key Numbers
173 patients underwent TAVI. Elevated BNP is currently the only biomarker in aortic valve guidelines (for asymptomatic severe stenosis).
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Combined use of high-sensitivity troponin-T and NT-proBNP natriuretic peptide provides superior hear
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Utility of High-Sensitivity Cardiac Troponin-T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Survival, Quality of Life, and Functional Status Changes After Transcatheter Aortic Valve Implantation.
- Published In:
- Journal of the American Heart Association, 14(21), e039898 (2025)
- Authors:
- Andrews, Tyler, Jabri, Ahmad, McBride, Patrick, Gelovani, David, Beidoun, Mohamad, Giustino, Gennaro, Krafchak, Stephen, Gladney, Stephen, Holmes, Danielle, Wyman, Janet F, Wang, Dee Dee, Eng, Marvin, Aronow, Herb, Lanfear, Dave, O'Neill, William, Engel Gonzalez, Pedro, O'Neill, Brian, Villablanca, Pedro, Lee, James, Jacobsen, Gordon, Cook, Bernard, McCord, James, Frisoli, Tiberio M
- Database ID:
- RPEP-09947
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Combined use of high-sensitivity troponin-T and NT-proBNP natriuretic peptide provides superior heart failure diagnostic utility compared to either biomarker alone.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09947APA
Andrews, Tyler; Jabri, Ahmad; McBride, Patrick; Gelovani, David; Beidoun, Mohamad; Giustino, Gennaro; Krafchak, Stephen; Gladney, Stephen; Holmes, Danielle; Wyman, Janet F; Wang, Dee Dee; Eng, Marvin; Aronow, Herb; Lanfear, Dave; O'Neill, William; Engel Gonzalez, Pedro; O'Neill, Brian; Villablanca, Pedro; Lee, James; Jacobsen, Gordon; Cook, Bernard; McCord, James; Frisoli, Tiberio M. (2025). Utility of High-Sensitivity Cardiac Troponin-T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Survival, Quality of Life, and Functional Status Changes After Transcatheter Aortic Valve Implantation.. Journal of the American Heart Association, 14(21), e039898. https://doi.org/10.1161/JAHA.124.039898
MLA
Andrews, Tyler, et al. "Utility of High-Sensitivity Cardiac Troponin-T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Survival, Quality of Life, and Functional Status Changes After Transcatheter Aortic Valve Implantation.." Journal of the American Heart Association, 2025. https://doi.org/10.1161/JAHA.124.039898
RethinkPeptides
RethinkPeptides Research Database. "Utility of High-Sensitivity Cardiac Troponin-T and N-Termina..." RPEP-09947. Retrieved from https://rethinkpeptides.com/research/andrews-2025-utility-of-highsensitivity-cardiac
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.